Clinical trial
The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With…
NCT00056368 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00056368 |
|---|---|
| Title | The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis |
| Official title | A Phase III, Double-Blind, Randomized, Multi-Center, Study of the Safety and Efficacy of Anidulafungin vs. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications. |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Vicuron Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Candidiasis |
| Intervention type | Drug |
| Interventions | Anidulafungin, Fluconazole |
| Enrollment | 256 |
| Start date | Mar 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Mar 12, 2003 |
| Last update posted | Oct 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: